X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (2574) 2574
Publication (441) 441
Book / eBook (42) 42
Book Review (21) 21
Book Chapter (10) 10
Conference Proceeding (3) 3
Dissertation (2) 2
Data Set (1) 1
Magazine Article (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (2025) 2025
index medicus (1461) 1461
animals (1290) 1290
oncology (996) 996
mice (794) 794
mutation (747) 747
cancer (618) 618
female (598) 598
proto-oncogene proteins - genetics (572) 572
proto-oncogene proteins p21 (571) 571
cell line, tumor (567) 567
cell biology (554) 554
biochemistry & molecular biology (552) 552
proto-oncogene proteins p21 - genetics (550) 550
signal transduction (542) 542
ras proteins - genetics (539) 539
proto-oncogene proteins p21 - metabolism (499) 499
male (462) 462
apoptosis (437) 437
receptor, epidermal growth factor - antagonists & inhibitors (395) 395
phosphorylation (379) 379
expression (378) 378
research (366) 366
genetic aspects (335) 335
activation (328) 328
antineoplastic agents - pharmacology (312) 312
colorectal neoplasms - genetics (308) 308
signal transduction - drug effects (308) 308
proteins (306) 306
antineoplastic agents - therapeutic use (296) 296
enzyme inhibitors - pharmacology (296) 296
colorectal neoplasms - drug therapy (291) 291
article (289) 289
tumors (288) 288
middle aged (283) 283
ras (273) 273
apoptosis - drug effects (269) 269
proto-oncogene proteins - metabolism (255) 255
gene expression (251) 251
aged (249) 249
colorectal cancer (245) 245
cetuximab (238) 238
chemotherapy (238) 238
multidisciplinary sciences (229) 229
rats (228) 228
cell proliferation - drug effects (226) 226
colorectal neoplasms - pathology (224) 224
kinases (219) 219
proto-oncogene proteins p21 - antagonists & inhibitors (219) 219
cell cycle (216) 216
proto-oncogene proteins b-raf - genetics (216) 216
cell proliferation (214) 214
kras (213) 213
lung neoplasms - genetics (211) 211
cell line (208) 208
protein kinase inhibitors - pharmacology (208) 208
research article (207) 207
growth (206) 206
adult (205) 205
gene expression regulation, neoplastic (204) 204
care and treatment (203) 203
health aspects (203) 203
phosphatidylinositol 3-kinases - metabolism (199) 199
proto-oncogene proteins c-akt - metabolism (198) 198
physiological aspects (197) 197
cells, cultured (196) 196
oncogenes (192) 192
lung neoplasms - drug therapy (187) 187
neoplasms (186) 186
tumor cells, cultured (186) 186
cells (184) 184
genetics & heredity (184) 184
ras proteins - metabolism (181) 181
transfection (181) 181
mice, nude (176) 176
tumor suppressor protein p53 - metabolism (175) 175
xenograft model antitumor assays (172) 172
receptor, epidermal growth factor - genetics (165) 165
protein kinase inhibitors - therapeutic use (163) 163
lung neoplasms - pathology (160) 160
k-ras (159) 159
mutations (159) 159
treatment outcome (158) 158
metastasis (156) 156
blotting, western (155) 155
phosphatidylinositol 3-kinases - antagonists & inhibitors (155) 155
oncogene protein p21 - metabolism (154) 154
inhibition (150) 150
prognosis (150) 150
analysis (146) 146
lung cancer (146) 146
molecular targeted therapy (145) 145
antibodies, monoclonal - therapeutic use (144) 144
biology (144) 144
genes, ras (144) 144
protein (144) 144
antineoplastic combined chemotherapy protocols - therapeutic use (143) 143
therapy (143) 143
enzyme activation (142) 142
growth-factor receptor (142) 142
more...
Library Location Library Location
Library Location Library Location
X
Sort by Item Count (A-Z)
Filter by Count
Gerstein Science - Stacks (35) 35
UofT at Mississauga - Stacks (5) 5
Collection Dvlpm't (Acquisitions) - Closed Orders (3) 3
Collection Dvlpm't (Acquisitions) - Vendor file (2) 2
UTL at Downsview - May be requested (2) 2
Gerstein Science - Circulation Desk (1) 1
Online Resources - Online (1) 1
Providence Healthcare - Withdrawn (1) 1
St. Michael's Hospital - Circulation Desk (1) 1
St. Michael's Hospital - Stacks (1) 1
Sunnybrook Health Sciences Centre - Sunnybrook Stacks (1) 1
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (2587) 2587
French (12) 12
Japanese (5) 5
German (4) 4
Russian (4) 4
Chinese (3) 3
Czech (2) 2
Hungarian (2) 2
Croatian (1) 1
Hebrew (1) 1
Portuguese (1) 1
Spanish (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal Article
Genes and Development, ISSN 0890-9369, 05/2013, Volume 27, Issue 10, pp. 1101 - 1114
Tumorigenesis results from dysregulation of oncogenes and tumor suppressors that influence cellular proliferation, differentiation, apoptosis, and/or... 
Huwe1 | c-Myc | Mule | Ras | p21 | Miz1 | DNA-DAMAGE | KERATINOCYTE GROWTH | DEVELOPMENTAL BIOLOGY | CELL BIOLOGY | BASE EXCISION-REPAIR | HUWE1 UBIQUITIN LIGASE | NEGATIVE REGULATION | GENETICS & HEREDITY | ARF TUMOR-SUPPRESSOR | DIFFERENTIATION | MIZ-1 | HUMAN CANCER | Protein Inhibitors of Activated STAT - deficiency | Tetradecanoylphorbol Acetate - pharmacology | 9,10-Dimethyl-1,2-benzanthracene - pharmacology | Male | Protein Inhibitors of Activated STAT - metabolism | Cyclin-Dependent Kinase Inhibitor p15 - biosynthesis | Oncogene Protein p21(ras) - metabolism | Cyclin-Dependent Kinase Inhibitor p16 | Oncogene Protein p21(ras) - antagonists & inhibitors | Cyclin-Dependent Kinase Inhibitor p21 - genetics | Cell Transformation, Neoplastic - genetics | Cyclin-Dependent Kinase Inhibitor p15 - genetics | Nuclear Proteins - deficiency | Protein Inhibitors of Activated STAT - genetics | Cyclin-Dependent Kinase Inhibitor p21 - metabolism | Female | Nuclear Proteins - genetics | Protein Inhibitors of Activated STAT - antagonists & inhibitors | Skin Neoplasms - pathology | Cyclin-Dependent Kinase Inhibitor p21 - biosynthesis | Signal Transduction | Down-Regulation | Cells, Cultured | Ubiquitin-Protein Ligases - metabolism | Nuclear Proteins - metabolism | Skin Neoplasms - chemically induced | Proto-Oncogene Proteins c-myc - metabolism | Mice, Knockout | Skin Neoplasms - metabolism | Keratinocytes - pathology | Animals | Tumor Suppressor Protein p53 | Keratinocytes - drug effects | Keratinocytes - metabolism | Nuclear Proteins - antagonists & inhibitors | Proto-Oncogene Proteins c-myc - deficiency | Skin Neoplasms - genetics | Proto-Oncogene Proteins c-myc - antagonists & inhibitors | Ubiquitin-Protein Ligases - deficiency | Mice | Proto-Oncogene Proteins c-myc - genetics | Cyclin-Dependent Kinase Inhibitor p15 - metabolism | Genes, ras | Ubiquitin-Protein Ligases - genetics | Oncogene Protein p21(ras) - genetics | Carcinogenesis | Ras genes | Analysis | Research Paper
Journal Article
Nature, ISSN 0028-0836, 05/2013, Volume 497, Issue 7451, pp. 638 - 642
Journal Article
Journal Article
Clinical Cancer Research, ISSN 1078-0432, 04/2012, Volume 18, Issue 8, pp. 2316 - 2325
Purpose: This study evaluated the clinical relevance of the dual-targeting strategy involving PI3K/AKT/mTOR and RAF/MEK/ERK pathways. Experimental Design: We... 
COLON-CANCER | METASTATIC MELANOMA | PIK3CA MUTATIONS | PI3K | ONCOLOGY | COLORECTAL-CANCER | RESISTANCE | BRAF | ANTITUMOR-ACTIVITY | MEK INHIBITORS | TUMORS | Neoplasms - metabolism | Extracellular Signal-Regulated MAP Kinases - drug effects | TOR Serine-Threonine Kinases - metabolism | Proto-Oncogene Proteins p21(ras) - genetics | Humans | Middle Aged | Extracellular Signal-Regulated MAP Kinases - antagonists & inhibitors | Male | Phosphatidylinositol 3-Kinases - metabolism | Extracellular Signal-Regulated MAP Kinases - metabolism | Molecular Targeted Therapy | Phosphatidylinositol 3-Kinases - antagonists & inhibitors | Extracellular Signal-Regulated MAP Kinases - genetics | Proto-Oncogene Proteins c-akt - genetics | TOR Serine-Threonine Kinases - antagonists & inhibitors | Young Adult | MAP Kinase Signaling System - genetics | TOR Serine-Threonine Kinases - genetics | Neoplasms - genetics | Aged, 80 and over | Adult | Female | Proto-Oncogene Proteins c-akt - metabolism | Proto-Oncogene Proteins p21(ras) - metabolism | Neoplasms - drug therapy | Phosphatidylinositol 3-Kinases - genetics | MAP Kinase Signaling System - drug effects | Proto-Oncogene Proteins B-raf - genetics | Proto-Oncogene Proteins p21(ras) - antagonists & inhibitors | Adolescent | Aged | Mutation | Proto-Oncogene Proteins c-akt - antagonists & inhibitors
Journal Article
Cancer Cell, ISSN 1535-6108, 02/2014, Volume 25, Issue 2, pp. 243 - 256
Mutations in are prevalent in human cancers and universally predictive of resistance to anticancer therapeutics. Although it is widely accepted that... 
ACTIVATION | INHIBITION | ONCOGENIC RAS | TUMOR PROGRESSION | CHK1 | ONCOLOGY | INITIATION | COMBINATION | SUPPRESSION | ATR | KINASES | CELL BIOLOGY | Neoplasms - metabolism | Protein Kinases - metabolism | ras Proteins - genetics | Proto-Oncogene Proteins p21(ras) - genetics | Humans | ras Proteins - metabolism | Drug Resistance, Neoplasm | Phosphatidylinositol 3-Kinases - metabolism | GTP Phosphohydrolases - antagonists & inhibitors | Ribosomal Protein S6 Kinases, 90-kDa - metabolism | Flow Cytometry | Neoplasms - genetics | DNA Damage - genetics | Female | Antineoplastic Agents - pharmacology | Membrane Proteins - metabolism | Phosphorylation - drug effects | Proto-Oncogene Proteins c-akt - metabolism | Proto-Oncogene Proteins p21(ras) - metabolism | DNA Damage - drug effects | Proto-Oncogene Proteins - metabolism | Cell Survival - drug effects | Membrane Proteins - genetics | Proto-Oncogene Proteins - genetics | Mutation - genetics | Animals | GTP Phosphohydrolases - metabolism | Membrane Proteins - antagonists & inhibitors | Mitogen-Activated Protein Kinase 3 - metabolism | GTP Phosphohydrolases - genetics | Mice, Nude | Proto-Oncogene Proteins p21(ras) - antagonists & inhibitors | Checkpoint Kinase 1 | Mice | Cell Transformation, Neoplastic - pathology | Neoplasms - pathology | Mitogen-Activated Protein Kinase 1 - metabolism | Chemotherapy | DNA damage | DNA | Genetic research | DNA repair | Cancer | Tumors
Journal Article
Nature, ISSN 0028-0836, 08/2017, Volume 548, Issue 7666, pp. 234 - 238
Journal Article
Journal of Clinical Oncology, ISSN 0732-183X, 2018, Volume 36, Issue 9, pp. 911 - 919
Journal Article
Nature Medicine, ISSN 1078-8956, 10/2012, Volume 18, Issue 10, pp. 1503 - 1510
Journal Article
Cell, ISSN 0092-8674, 02/2017, Volume 168, Issue 5, pp. 878 - 889.e29
Journal Article